journal article·2024-02-21Open access

Polycarbonate-Based Copolymer Micelles as Biodegradable Carriers of Anticancer Podophyllotoxin or Juniper Extracts

Radostina G. Kalinova, Ivaylo V. Dimitrov, Diana I. Ivanova, Yana E. Ilieva, Alexander N. Tashev, Maya M. Zaharieva, George Angelov, Hristo M. Najdenski

Abstract

Podophyllotoxin (PPT) is used in the industrial production of efficient anticancer, antiviral and other drugs. Sinopodophyllum hexandrum or Podophyllum peltatum are natural sources of PPT, but at present they are considered as endangered species. Their PPT content is variable, depending on the growing conditions. Searching for new sources of PPT, some representatives of the genus Juniperus were found to exhibit efficient PPT biosynthesis. However, PPT is highly toxic and poorly soluble in water compound, which limits its clinical applications. In this connection, amphiphilic polymer micelles are considered to be suitable PPT carriers, aimed at increase in water solubility and decrease in toxicity. The present research deals with the evaluation of MPEG–polycarbonate block copolymer micelles loaded with PPT or juniper extracts. The active component-loaded polymer nanocarriers were characterized by dynamic and electrophoretic light scattering, as well as by transmission electron microscopy. The active component loading efficiency and loading capacity were also determined. Highly efficient antiproliferative activity of the loaded micelles was determined in a panel of cancer cell lines. The obtained amphiphilic nanocarriers, loaded with PPT-containing bioactive components, have application in future in vivo preclinical trials of their pharmacokinetics and pharmacodynamics as potential therapeutical agents in the prospective nanomedicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Plant-derived Lignans Synthesis and Bioactivity · Cancer Treatment and Pharmacology · Biological Activity of Diterpenoids and Biflavonoids

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

Institute of Chemical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

Department of Dendrology, University of Forestry, 1797 Sofia, Bulgaria

Funding

European Regional Development Fund within the Operational Programme Science and Education for Smart Growth 2014–2020

References (33)

Show source-provided references
1. Satyannarayana, B. (2022). Current Research of Nanotechnology in Science and Engineering, Bhumi Publishing. [1st ed.]. Available online: https://www.bhumipublishing.com/books/.
2. The ‘right’ size in nanobiotechnology10.1038/nbt872 ↗
3. Garcia-Oliveira, P., Otero, P., Pereira, A.G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., and Prieto, M.A. (2021). Status and challenges of plant-anticancer compounds in cancer treatment. Pharmaceuticals, 14.10.3390/ph14020157 ↗
4. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano-Formulations10.2174/1389200223666220905162245 ↗
5. Nano-Phytoconstituents and its recent advancement in Anticancer efficacy
6. Recent advances in herbal nanomedicines for cancer treatment10.2174/1874467213666200525010624 ↗
7. Lipid-based drug delivery systems in cancer therapy: What is available and what is yet to come10.1124/pr.115.012070 ↗
8. Shah, Z., Gohar, U., Jamshed, I., Mushtaq, A., Mukhtar, H., Zia-Ui-Haq, M., Toma, S., Manea, R., Moga, M., and Popovici, B. (2021). Podophyllotoxin: History, recent advances and future prospects. Biomolecules, 11.10.3390/biom11040603 ↗
9. Motyka, S., Jafernik, K., Ekiert, H., Sharifi-Rad, J., Calina, D., Al-Omari, B., Szopa, A., and Cho, W.C. (2023). Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy. Biomed. Pharmacother., 158.10.1016/j.biopha.2022.114145 ↗
10. Podophyllotoxin content in Podophyllum hexandrum Royle plants of known age of seed origin and grown at a lower altitude10.1007/s11738-006-0015-0 ↗
11. Podophyllotoxin and deoxypodophyllotoxin in Juniperus bermudiana and 12 other Juniperus species: Optimization of extraction, method validation, and quantification10.1021/jf201410p ↗
12. Ivanova, D., Nedialkov, P., Tashev, A., Kokanova-Nedialkova, Z., Olech, M., Nowak, R., Boyadzhieva, S., Angelov, G., and Yankov, D. (2023). Anticancer Podophyllotoxin Recovery from Juniper Leaves at Atmospheric and High Pressure Using Eco-Friendly Solvents. Plants, 12.10.3390/plants12071526 ↗
13. Ivanova, D., Nedialkov, P., Tashev, A., Olech, M., Nowak, R., Ilieva, Y., Kokanova-Nedialkova, Z., Atanasova, T., Angelov, G., and Najdenski, H. (2021). Junipers of Various Origins as Potential Sources of the Anticancer Drug Precursor Podophyllotoxin. Molecules, 26.10.3390/molecules26175179 ↗
14. Shi, R.J., Fan, H.Y., Yu, X.H., Tang, Y.L., Jiang, J., and Liang, X.H. (2022). Advances of podophyllotoxin and its derivatives: Patterns and mechanisms. Biochem. Pharmacol., 200.10.1016/j.bcp.2022.115039 ↗
15. Kotta, S., Aldawsari, H.M., Badr-Eldin, S.M., Nair, A.B., and YT, K. (2022). Progress in polymeric micelles for drug delivery applications. Pharmaceutics, 14.10.3390/pharmaceutics14081636 ↗
16. To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives10.1016/j.addr.2021.114079 ↗
17. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval10.1016/j.addr.2020.09.009 ↗
18. Aliphatic polycarbonates from cyclic carbonate monomers and their application as biomaterials10.1021/acs.chemrev.0c00883 ↗
19. Polymer micellar aggregates of novel amphiphilic biodegradable graft copolymer composed of poly(aspartic acid) derivatives: Preparation, characterization, and effect of pH on aggregation10.1002/app.22818 ↗
20. Hydrophobic modified poly(L-glutamic acid) graft copolymer micelles with ultrahigh drug loading capacity for anticancer drug delivery10.1002/pi.6342 ↗
21. Highly loaded deoxypodophyllotoxin nano-formulation delivered by methoxy polyethylene glycol-block-poly (D,L-lactide) micelles for efficient cancer therapy10.1080/10717544.2020.1716875 ↗
22. Alven, S., Nqoro, X., Buyana, B., and Aderibigbe, B.A. (2020). Polymer-drug conjugate, a potential therapeutic to combat breast and lung cancer. Pharmaceutics, 12.10.3390/pharmaceutics12050406 ↗
23. Tumor targeted micellar nanocarriers assembled from epipodophyllotoxin-based amphiphiles10.1039/C9NR01068H ↗
24. Podophyllotoxin-polyacrylic acid conjugate micelles: Improved anticancer efficacy against multidrug-resistant breast cancer10.1186/s43046-020-00053-1 ↗
25. Kalinova, R., Grancharov, G., Doumanov, J., Mladenova, K., Petrova, S., and Dimitrov, I. (2023). Green synthesis and the evaluation of a functional amphiphilic block copolymer as a micellar curcumin delivery system. Int. J. Mol. Sci., 24.10.3390/ijms241310588 ↗
26. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions10.1016/j.jconrel.2021.02.031 ↗
27. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
28. (2017). Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity (Standard No. ISO 10993-5:2009).
29. Self-assembled micelles prepared from bio-based hydroxypropyl methyl cellulose and polylactide amphiphilic block copolymers for anti-tumor drug release10.1016/j.ijbiomac.2020.03.094 ↗
30. Effects of polymer terminal group inside micelle core on paclitaxel loading promoting and burst release suppressing10.21037/jgo-23-206 ↗
31. Kamenova, K., Radeva, L., Konstantinov, S., Petrov, P.D., and Yoncheva, K. (2023). Copolymeric micelles of poly(ε-caprolactone) and poly(methacrylic acid) as carriers for the oral delivery of resveratrol. Polymers, 15.10.3390/polym15183769 ↗
32. Investigating the optimal size of anticancer nanomedicine10.1073/pnas.1411499111 ↗
33. Hemocompatibility testing for nanomedicines and biologicals: Predictive assays for complement mediated infusion reactions10.1515/ejnm-2012-0002 ↗